| MRNS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MRNS shares outstanding history going back to 7/31/2014:
Also see: MRNS Market Cap History MRNS YTD Return |
MRNS Shares Outstanding History — Marinus Pharmaceuticals Share Count Over Time
As of 11/5/2024 Marinus Pharmaceuticals has 55.19 million MRNS shares outstanding. Investors often track the MRNS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MRNS share count trends over time, with 42 historical shares outstanding datapoints presented, dating back to 7/31/2014.
| MRNS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRNS Historical Shares Outstanding: +32.52% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MRNS Stock Price Chart |
| About Marinus Pharmaceuticals Inc |
| Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. Co. is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Co.'s new drug application for the use of ZTALMY oral suspension CV for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in patients two years of age and older. We show 42 historical shares outstanding datapoints in our coverage of MRNS's shares outstanding history. Understanding the changing numbers of MRNS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MRNS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MRNS by allowing them to research MRNS shares outstanding history as well as any other stock in our coverage universe. |
| MRNS Current Stock Quote |
Quotes delayed 20 minutes  Free MRNS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MRNS Share Performance |
| Shares Outstanding Peers |
| Marinus Pharmaceuticals (MRNS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MRSN Shares Outstanding History MRTX Shares Outstanding History MRVI Shares Outstanding History MSON Shares Outstanding History MTCR Shares Outstanding History MTEM Shares Outstanding History MTVA Shares Outstanding History MXCT Shares Outstanding History MYGN Shares Outstanding History MYL Shares Outstanding History More Healthcare companies » |
MRNS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
